0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
CLINICAL NOTES |

Combined Effect of Sodium Warfarin and Phenylbutazone

Milton J. Eisen, MD
JAMA. 1964;189(1):64-65. doi:10.1001/jama.1964.03070010070021.
Text Size: A A A
Published online

IN THE COURSE of long-term ambulatory management of cardiac patients with an anticoagulant, sodium warfarin, five individuals also received phenylbutazone for various arthritic manifestations. In all patients a significant dramatic increase in the prothrombin time was observed, at times accompanied by hemorrhagic episodes. In each case, the unexpected effects occurred rapidly at the end of the usual course of treatment with 200 to 300 mg of phenylbutazone daily for five to seven days.

A relationship of phenylbutazone to some factors of the coagulation mechanism has been suggested by several investigators, though the available reports do not support consistently positive ideas. For example, Humble1 stated that the clotting of blood was diminished by phenylbutazone alone, but that the prothrombin time was also lengthened in 30% of the patients receiving this drug. In two individuals it was prolonged as much as two minutes. These findings have not been duplicated by other

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();